Responses
Immune cell therapies and immune cell engineering
Original research
Therapeutic Inducers of Natural Killer cell Killing (ThINKK): preclinical assessment of safety and efficacy in allogeneic hematopoietic stem cell transplant settings
Compose a Response to This Article
Other responses
No responses have been published for this article.
